Just ‘Stay Alive for the Next 10 Years’ – Anti-Ageing Drugs Are Coming, Says Billionaire Investor
Billionaire investor Jim Mellon told attendees at Spear’s 500 Live that the first truly anti‑ageing drugs could hit the market within a decade. He highlighted clinical‑stage senolytics, partial genetic reprogramming and repurposed weight‑loss medicines as the leading candidates to halt or reverse cellular ageing. The longevity sector, already worth about $800 billion, is projected to swell to $1.87 trillion by 2034, drawing backing from tech moguls such as Jeff Bezos and Elon Musk. Mellon warned that longer healthspans will force a rethink of retirement and senior‑living models.
SJMC Was Neglected for Years; We Chose to Fix It
San Juan City has earmarked roughly US$10 million to overhaul its public hospital, San Juan Medical Center (SJMC). Since the mayor took office in 2019, the facility has been upgraded from a Level 1 to a DOH Level 2 hospital, adding MRI, CT,...
California Regulators Post Proposed Medical Evaluator Rules
The California Division of Workers' Compensation released an informal draft of rules to clarify eligibility for qualified medical evaluators (QMEs) and to permit remote‑only office listings. The proposal revises timelines for agency responses to applications and QME placement exams. It...
Black Patients, Women with UC Less Likely to Undergo Colectomy
A retrospective analysis of 727,515 ulcerative colitis admissions (2016‑2020) found that Black, Hispanic and female patients are significantly less likely to receive colectomy, the definitive surgery for refractory disease. After adjusting for clinical factors, Black patients were about 50% less...
EnGene's Shares Crash on Updated Pivotal Bladder Cancer Data
EnGene Therapeutics reported Phase 2 data for its experimental bladder‑cancer therapy that revealed a modest 5% objective response rate and safety signals in more than half of patients. The results triggered an 80% plunge in the Canadian biotech’s stock, wiping...
Q&A: Evaluating the Use of Complementary and Alternative Medicines in Dermatology
A new review in the Journal of Clinical and Aesthetic Dermatology finds that 35‑65% of American patients with skin conditions turn to complementary and alternative medicines (CAM). Commonly used agents include tea‑tree oil, green‑tea extract, garlic‑derived ajoene, honey mixtures and...
Future-Proof Strategies for Medical Campus Construction Featured at IFHE World Congress
McCarthy Building Companies’ VP Joey Khaled highlighted that $300 million projects, once considered mega, are now routine, with $1 billion-plus campuses emerging across the United States. He cited the 4.9‑million‑sq‑ft Children’s Health pediatric campus in Dallas and the 1.2‑million‑sq‑ft Harris Health hospital...
Are Health Insurers Out of the Woods After a Tough 2025?
Health insurers faced a challenging 2025, with many cutting or withdrawing profit forecasts amid rising claim costs, regulatory headwinds, and slower enrollment growth. In the first half of 2026, several carriers reported modest earnings rebounds driven by higher Medicare Advantage...
Debunked Episode 26: A Conversation on How to Improve Healthcare
The U.S. saw measles cases fall from 2,214 last year to 1,923 so far this year, prompting a heated Senate HELP hearing where HHS Secretary Robert Kennedy Jr. and Senator‑physician Bill Cassidy debated vaccine policy. In the same episode, MedCity News editor...
Employees With Medical Conditions Challenge C.D.C. In-Office Requirement
The CDC has mandated that employees with serious medical conditions return to the office, revoking long‑standing remote‑work accommodations after a January 2025 executive order. The Department of Health and Human Services interpreted the order strictly, cancelling all disability exemptions across the...
Longevity Fanatics Are Seeking Out Stem Cells—But Is It Safe?
Stem‑cell clinics are expanding from medical treatment into high‑priced wellness and anti‑aging services, offering injections of mesenchymal cells, Wharton’s jelly, and MUSE pluripotent cells. Celebrities such as Cristiano Ronaldo and the Kardashians have popularized these unapproved therapies, prompting a surge in...
Diabetes Detection Needs Better Tools. They’re on the Way
Researchers warn that traditional HbA1c testing misses millions at risk for diabetes, especially in Black and South Asian populations. New AI‑driven tools are leveraging continuous glucose monitors and routine electrocardiograms to flag metabolic dysfunction years before blood sugar spikes. Stanford’s...
Blackstone Puts $250M Into Anagram to Tackle Cystic Fibrosis Complication
Blackstone Life Sciences announced a $250 million investment in Anagram, a biotech developing a novel therapy for a cystic fibrosis complication. The capital, drawn from one of the industry’s largest private life‑science funds, will accelerate Anagram’s late‑stage clinical trials, manufacturing scale‑up,...
Anesthetic and Analgesic Drug Products Advisory Committee Charter
The FDA has established the Anesthetic and Analgesic Drug Products Advisory Committee to provide expert advice on the safety and efficacy of marketed and investigational analgesics, including abuse‑deterrent opioids and anesthetic products. The charter, approved April 23, 2026, outlines a...
AI Copilot in Development Guides Healthy Cooking Step-by-Step
Stanford Medicine researchers are building an AI cooking copilot that offers real‑time, step‑by‑step guidance for healthy, culturally tailored meals. The system draws on data from a teaching‑kitchen program where 16 staff participants received detailed instruction on sequencing, temperature, and flavor...
Wisdom Ventures Closes $77.7M Fund II to Invest in AI-Native Wellbeing Startups
Wisdom Ventures announced the close of its $77.7 million Fund II, a ten‑fold jump from its $10 million Fund I. The round is backed by Silicon Valley heavyweights such as Reid Hoffman, Evan Sharp and Stewart Butterfield, and adds former U.S. Surgeon General Dr. Vivek Murthy...
Entrada Stock Falls on Duchenne Data; Wegovy Expands Access
Entrada Therapeutics reported topline results from its Duchenne muscular dystrophy (DMD) cohort of six patients, showing no meaningful functional improvement. The disappointing data sent Entrada's shares down roughly 15% in after‑hours trading. Meanwhile, Novo Nordisk announced expanded payer coverage for...
Insmed Tanks On Its Most Important Launch; Why Analysts Remain Bullish
Insmed’s newly launched lung drug Brinsupri posted first‑quarter sales of $208 million, beating sell‑side forecasts but falling short of the $230 million buy‑side target. The miss triggered a near‑17% plunge in the stock, sending shares to $114.25, their lowest level since August....
About Half of Patients with Metastatic Lung Cancer Don’t Get Treatment, Study Finds
A JAMA Oncology study of over 250,000 Medicare beneficiaries shows that only 48% of patients with metastatic lung cancer received life‑extending therapies between 2006 and 2021, a modest rise from 45%. Despite dozens of new chemo, immunotherapy and targeted drugs...
Sharma Lab Deploys Open-LIFU for Multidisciplinary Neurological Research at NC State, UNC
Openwater has partnered with the Sharma Lab at NC State and UNC‑Chapel Hill to deploy its open-source low‑intensity focused ultrasound (Open‑LIFU) platform for multidisciplinary neurological research. The collaboration will test the device’s feasibility in conditions such as transverse myelitis, essential...
Genetic Testing May Unlock Vitamin D's Potential for Diabetes Prevention
A JAMA Network Open analysis of the D2d trial shows that daily 4,000 IU vitamin D₃ reduced type 2 diabetes incidence by 19% among prediabetic adults carrying the ApaI AC or CC variants of the vitamin D receptor gene. The same high‑dose regimen had...
The Health Impact Alliance Collaborates with Infineon to Redefine Independent Living for the Aging Population
The Health Impact Alliance (HIA) has partnered with semiconductor leader Infineon Technologies to build a connected healthcare ecosystem for seniors. Infineon will supply its AIROC CYW55512 Wi‑Fi 6/Bluetooth 6 combo IC and PSOC Edge E84 microcontroller, delivering low‑power, secure, edge‑AI capabilities. The first...
FDA Reverses Course on Atara, Pierre Fabre’s Twice-Rejected Cell Therapy After Prasad’s Exit
Atara Biotherapeutics and Pierre Fabre’s EBV‑positive PTLD cell therapy Ebvallo received a regulatory U‑turn after FDA CBER director Vinay Prasad stepped down. The agency now says a single‑arm study with an appropriate historical control can satisfy the “adequate and well‑controlled” requirement, allowing...
Refrigerated Food Lockers at Harris Health Help Patients with Food Insecurity Battle Diabetes
Harris Health introduced refrigerated food lockers as part of its Food Rx program to give diabetic patients facing food insecurity easier access to fresh, nutritious foods. Backed by a $500,000 Cigna grant and a partnership with the Houston Food Bank,...
Fewer EHR Choices Mean Higher Prices for Health Systems
EHR market consolidation is leaving health systems with fewer vendor options, according to Altera Digital Health’s Marcus Perez. As the industry narrows to a handful of dominant platforms, hospitals lose bargaining power and face higher contract prices. The trend threatens...
Electric‐Eel‐Inspired Ionic Power Source Microneedles With Self‐Reporting Structural Colors for Wound Healing
Researchers have engineered ionic power source microneedles (IPSMs) that combine electric‑eel‑inspired ion transport with chameleon‑like structural colors for wound care. The three‑layer device creates an internal K⁺‑driven electric field, delivering electrical stimulation that accelerates tissue repair. Integrated silver nanoparticles provide...
Transforming CTMS: An Operating Layer for Real-Time Trial Execution
Clinical trial management systems (CTMS) are evolving from static record‑keeping tools into an operating layer that adds real‑time, AI‑driven reasoning to coordinate complex, multi‑system studies. The article highlights that Phase III trials now span a median of more than ten countries,...
Tricuspid Training Series: Evaluation and Management of Patients with Severe Tricuspid Regurgitation
On May 7, 2026, TCTMD released a new episode of its Heart Valve Matters podcast titled “Tricuspid Training Series: Evaluation and Management of Patients with Severe Tricuspid Regurgitation.” Hosts Rick Nishimura and Michael Mack discuss the growing prevalence of severe...
Md. County Debates Grant-Funded Whole Blood Program for EMS
Somerset County, Maryland, is debating a MIEMSS‑funded whole‑blood program that would place the lifesaving product on local ambulances for at least five years. Emergency physicians argue the blood can curb the 75% of preventable trauma deaths that occur before hospital...
3D-MIND: A Flexible Device that Can Be Integrated with Living Brain Cells
Researchers at Princeton have unveiled 3D-MIND, a flexible electronic mesh that can be embedded inside three‑dimensional cultures of living brain cells. The device integrates sensors and micro‑stimulators within the neural tissue, enabling stable recording and stimulation for up to six...
Funding Roundup: Kanvas Biosciences, LTZ Therapeutics Draw Investor Interest for Next-Generation Cancer Immunotherapies
Kanvas Biosciences and LTZ Therapeutics announced a combined $86 million financing round to accelerate next‑generation cancer immunotherapies. Kanvas closed a $48 million Series A to push its microbiome‑based platform and the lead candidate KAN‑001 toward clinical trials. LTZ secured $38 million to expand its...
Amgen Adds $300M to Puerto Rico Budget; Novartis to Exit Oral Drug Factory in Germany
Amgen announced an additional $300 million investment to expand its manufacturing footprint in Puerto Rico, bringing its total U.S. capital outlay to nearly $2 billion over the past year. The funding will support new bioprocessing lines and increase the island’s capacity for...
Los Angeles County Works to Modernize Its Public Health Data Infrastructure
Los Angeles County’s Department of Public Health is overhauling its data infrastructure by adopting the Fast Healthcare Interoperability Resources (FHIR) standard, a move driven by the CDC Foundation’s Workforce Acceleration Initiative (WAI). Data engineer Joe Martin is leading efforts to...
Okla. EMS Director Sounds Alarm on Funding Crisis
Woodward County EMS Director Pebbles Luddington warned that rising call volumes and stagnant reimbursements are creating a funding shortfall. The agency billed more than $3 million last year but had to write off $1.6 million due to insurance contracts and unpaid balances....
Breaking Down Frontline BTK Inhibitor Selection in CLL: Kerry Rogers, MD
When choosing a frontline Bruton tyrosine kinase (BTK) inhibitor for chronic lymphocytic leukemia, clinicians currently rely on FDA‑approved covalent agents, with acalabrutinib and zanubrutinib favored for their superior cardiovascular safety over ibrutinib. Emerging data from the 2025 ASH meeting show...
Infinitus Introduces The First Solution to Evaluate Every Healthcare Interaction Led by AI or Humans
Infinitus Systems launched Lens, a conversation insights engine that evaluates every healthcare interaction—AI or human—by scoring calls against unified criteria. It claims to provide 100% coverage, automatically detecting adverse events, product complaints, and compliance gaps, turning unstructured audio/text into structured...
STAT+: Pharmalittle: We’re Reading About Sanofi and an FDA Voucher, FDA Rethinking a Rejection, and More
Sanofi asked the FDA to withdraw its type 1 diabetes antibody teplizumab from the new fast‑track voucher program after Center for Drug Evaluation and Research director Tracy Beth Høeg publicly challenged a staff decision to approve the drug. The agency missed...
Patient Responsibility Is Rising — The Payment Experience Needs to Keep Up
Patients are now shouldering a larger share of healthcare costs as employers push higher premiums and deductibles, turning the payment experience into a key component of overall care satisfaction. Consumers expect the speed and simplicity of digital checkout, yet many...
Lack of Trust, Not Technology, Is What’s Stopping Health Plans From Meeting Their Mission and Financial Objectives
Health insurers are missing their mission and financial goals because members don’t trust the enrollment and service processes, not because of lacking technology. The upcoming HR1 rule, which adds an 80‑hour‑per‑month work requirement for Medicaid eligibility, turns these trust gaps...
Studying These Young Alzheimer's Patients Led to Breakthroughs. Trump Cut the Funding
The Dominantly Inherited Alzheimer Network (DIAN) has leveraged over 200 families with rare early‑onset Alzheimer’s gene mutations to uncover how the disease begins and to test amyloid‑targeting drugs that later reached the market. Its international registry, funded by the NIH...
Mont. Air Ambulance Service Seeks $2M for New Helicopter
ALERT, the Montana air‑ambulance service, has secured $3.5 million toward a $5.5 million Bell 429 helicopter and is now seeking the remaining $2 million from the community. The new twin‑engine rotorcraft will replace one of the existing Bell 407s, which will become a backup unit....
Eko Health Appoints Dr. Steven Steinhubl as CMO to Drive Cardiac AI and Global Clinical Strategy
Eko Health has named Dr. Steven R. Steinhubl, a leading cardiologist and digital‑medicine pioneer, as its chief medical officer. In his new role, Steinhubl will direct clinical strategy, research programs, and global partnerships to expand the adoption of Eko’s AI‑enabled...
STAT+: FDA Revisits a Rare Cancer Treatment It Rejected a Few Months Ago
The FDA has announced it will re‑evaluate a rare‑cancer therapy it dismissed just months earlier, citing new data submitted by the drug’s sponsor. The treatment, aimed at a subtype of metastatic sarcoma, originally failed to meet the agency’s efficacy benchmarks...
Amylyx Pharmaceuticals Q1 Earnings Call Highlights
Amylyx Pharmaceuticals reported that the Phase 3 LUCIDITY trial of its GLP‑1 antagonist avexitide completed dosing and is on track for a top‑line readout in Q3 2026. The company launched a U.S. expanded access program to treat up to 250 adults with...
Atara, Pierre Fabre's Cell Therapy to Get Another Shot at FDA Approval
Atara Biotherapeutics and Pierre Fabre Pharmaceuticals are reviving a T‑cell therapy that was rejected twice by the FDA. Regulators have signaled willingness to base a new approval decision on data from a Phase 3 trial, a departure from the earlier requirement...
Artera Launches AI Services Model and Agentic AI Squads for Specialty Care and FQHCs
Artera, formerly WELL Health, has introduced an AI Services Model that replaces generic SaaS with clinic‑specific, agentic solutions. The company deploys AI Service Squads—small teams of AI builders who work alongside providers—to deliver bespoke tools for scheduling, prior authorizations, referral...
‘People Should Be Talking About It’: Moves to Curtail Vaccine Information Obscures Important Science, Doctors Say
U.S. health agencies, including the FDA, CDC and NIH, have halted or censored several vaccine studies and presentations in 2026, citing methodological concerns or political language guidelines. A leaked Covid‑19 booster effectiveness study, pulled at the last minute, still shows...
Lilly, Gilead Lead Pharma’s M&A Boom
Pharma M&A activity surged in early 2026, with 24 deals announced by April and upfront payments topping $64 billion—almost triple the $24.5 billion recorded in the same period last year. The boom is driven by companies racing to refill pipelines before a...
The Rise of Trispecific Antibodies: Biopharma’s Next Big Bet After Bispecifics
Trispecific antibodies are emerging as the next wave of multispecific therapeutics, extending the success of bispecifics by simultaneously engaging three targets. More than 100 candidates are now in clinical trials, with major players such as Pfizer, Sanofi, AbbVie and Johnson...
The Rewards of Repetition
Anthony Guerra, founder of healthsystemCIO, argues that lasting operational excellence stems from tightly documented, repeatable workflows. He draws on Michael Gerber’s "E‑Myth" and the "small‑menu" concept from restaurant management to stress narrowing service scope for mastery. Guerra also highlights that...